Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
Hosted on MSN14h
AARP report: Medicare drug prices soarT he prices for 25 prescription drugs that Medicare’s Part D spends the most on have nearly doubled since they first became ...
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...
A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
The price growth for top drugs covered by Medicare Part D has exceeded inflation, according to a new AARP report. The 25 drugs studied have increased by an average of 98%, or nearly doubled ...
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...
The prices of the 25 most expensive brand-named drugs covered by Medicare Part D have nearly doubled, rising by an average of 98% since they entered the market, according to a new analysis by the AARP ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement on the first day the new $2,000 annual out-of-pocket spending cap for prescription ...
More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback